Previous 10 | Next 10 |
In its just-released 13F filing, the biotech-focused investment outfit discloses a 10.14M share stake in Verastem (VSTM).Shares are up 24.2% in after hours action. For further details see: Verastem up 24% after Baker Brothers reports stake
Two new breakout stocks for Week 6 of 2021 with better than 10% short-term upside potential. This past week three out of four stocks gained over 10% with VXRT gaining over 162% before pulling back midweek with average -2.96% portfolio declines to the close. 2021 MDA portfolio retu...
Shares of Verastem (NASDAQ: VSTM) sank Wednesday, trading down by 10% as of 2:30 p.m. EST after the company announced that Chief Medical Officer Dr. Frank Neumann is departing. He has decided to accept a position at an unspecified company. The surprise news comes just two weeks ...
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the departure of the Company’s Chief Medical Officer, Frank Neumann, M.D., Ph.D., effective immediately. ...
These 5 Biotech Penny Stocks Saw A Surge This Week, Will That Continue? Now that 2020 is behind us, 2021 could be the year for biotech penny stocks to take off. While the pandemic negatively affected most industries last year, biotech managed to come out better than before COVID sta...
Verastem has recently raised non-dilutive capital to bring two assets into phase 2 trials. The company's lead asset has the potential to address around 30% of all cancers and be combined with other medicines. This recent event along with a large market opportunity, makes Verastem ...
Biotech Penny Stocks to Watch Friday, January 8th was a relatively good day for many penny stocks . After a week of volatility in the stock market, Friday represented a relatively calm day for investors. Now that the year is off to a decent start, there are a few catalysts that rema...
Verastem (VSTM) appoints of industry veteran Frank Neumann, M.D., Ph.D., as chief medical officer to oversee the company’s clinical and regulatory strategy and medical affairs team.Appointment reflects progress of the company's RAS targeted therapy development program.Company...
Appointment Reflects Progress of Verastem’s RAS Targeted Therapy Development Program Verastem Recently Initiated Registration-Directed Trials with VS-6766 and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer and KRAS Mutant Non-Small Cell Lung Cancer Ve...
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will present at the virtual H.C. Wainwright BioConnect 2021 Conference. The fireside chat will ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
24.23%Change Percent:
Verastem Inc. Company Name:
VSTM Stock Symbol:
NASDAQ Market:
Verastem Inc. Website:
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock and accompanying warrants to purchase up to 13,333,334 shares of it...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock, as well as pre-funded warrants t...